Overactive Bladder Clinical Trial
Official title:
Is the Method of Screening in Sacral Neuromodulation a Prognostic Factor for Long-term Success?
The purpose of this study was to evaluate whether there is a difference in long-term outcome between patients screened with the percutaneous nerve evaluation (PNE) and first stage tined lead procedure (TLP).
Purpose: To evaluate if there is a difference in long-term outcome of sacral neuromodulation
(SNM) between patients screened with the percutaneous nerve evaluation (PNE) and first stage
tined lead procedure (TLP). Furthermore, we wanted to evaluate the outcome in patients who
only responded to screening with TLP after failure of initial PNE.
Materials and methods: We evaluated all patients screened for eligibility to receive SNM
treatment since the introduction of the tined lead technique in our centre in 2002. In May
2009, all implanted patients were asked to keep a voiding diary to record the effect of SNM
on urinary symptoms. Success was defined as more than 50% improvement in at least one of the
relevant voiding diary parameters compared to baseline. Chi square analysis was used to
evaluate differences in long-term outcome for the separate screening methods.
Results: In total, 92 patients were screened for SNM. Of the 76 patients who were screened
with PNE, 35 (46%) met the criteria for permanent implantation, whereas 11 of the 16
patients (69%) who underwent direct screening with TLP had permanent stimulators placed. Of
the 41 patients who failed PNE and subsequently underwent screening with TLP, 18 (44%) were
implanted with an INS after showing a successful response. The mean follow-up was 53 months
(range 35-77 months) at the time of voiding diary analysis. Statistical analysis showed no
difference between type of screening and long-term success (p=0.94).
Conclusion: Although first stage TLP is a more reliable screening tool than PNE, the
long-term success rate does not seem to be dependent on the screening method. Furthermore,
patients who initially failed PNE but responded to prolonged screening with TLP, appear to
be at least as successful in the long-term as patients who directly responded to PNE or TLP.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04578899 -
"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity"
|
N/A | |
Active, not recruiting |
NCT03556891 -
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
|
N/A | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT01955408 -
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
|
N/A | |
Recruiting |
NCT06201013 -
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
|
N/A | |
Recruiting |
NCT03727711 -
TPTNS: Home vs Hospital Treatment for Overactive Bladder
|
N/A | |
Completed |
NCT00768521 -
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
|
Phase 1 | |
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Completed |
NCT02211846 -
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
|
Phase 1 | |
Completed |
NCT02835846 -
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
|
Phase 4 | |
Completed |
NCT02857816 -
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
|
N/A | |
Completed |
NCT02202031 -
Controlling Urgency Through Relaxation Exercises
|
N/A | |
Withdrawn |
NCT02320201 -
Foot Neuromodulation for Overactive Bladder in Children
|
N/A | |
Not yet recruiting |
NCT01423838 -
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
|
Phase 4 | |
Not yet recruiting |
NCT01409512 -
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
|
N/A | |
Completed |
NCT01458197 -
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
|
Phase 2 | |
Completed |
NCT01437670 -
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
|
N/A | |
Terminated |
NCT01758848 -
Physical Therapy for Overactive Bladder
|
N/A | |
Withdrawn |
NCT01210859 -
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
|
N/A | |
Completed |
NCT00910520 -
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
|
Phase 3 |